PMID: 18728771Aug 30, 2008Paper

Quetiapine monotherapy for bipolar depression.

Neuropsychiatric Disease and Treatment
Michael E Thase

Abstract

Bipolar depression is more common, disabling, and difficult-to-treat than the manic and hypomanic phases that define bipolar disorder. Unlike the treatment of so-called "unipolar" depressions, antidepressants generally are not indicated as monotherapies for bipolar depressions and recent studies suggest that -even when used in combination with traditional mood stabilizers - antidepressants may have questionable value for bipolar depression. The current practice is that mood stabilizers are initiated first as monotherapies; however, the antidepressant efficacy of lithium and valproate is modest at best. Within this context the role of atypical antipsychotics is being evaluated. The combination of olanzapine and the antidepressant fluoxetine was the first treatment to receive regulatory approval in the US specifically for bipolar I depression. Quetiapine was the second medication to be approved for this indication, largely as the result of two pivotal trials known by the acronyms of BOLDER (BipOLar DEpRession) I and II. Both studies demonstrated that two doses of quetiapine (300 mg and 600 mg given once daily at bedtime) were significantly more effective than placebo, with no increased risk of patients switching into mania. Pooli...Continue Reading

References

Dec 1, 1993·Journal of Clinical Psychopharmacology·G L Zornberg, H G Pope
Dec 6, 2000·Journal of Clinical Psychopharmacology·M A FryeR M Post
May 12, 2001·Comprehensive Psychiatry·C VojtaM S Bauer
Mar 5, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Philip Seeman
Mar 5, 2002·The Journal of Clinical Psychiatry·Terence A Ketter, Joseph R Calabrese
Jun 5, 2002·Archives of General Psychiatry·Lewis L JuddMartin B Keller
Nov 12, 2003·Archives of General Psychiatry·Mauricio TohenAlan Breier
Nov 13, 2003·Journal of Affective Disorders·Matthias J MüllerArmin Szegedi
Nov 26, 2003·Bipolar Disorders·Joseph F Goldberg, Christine J Truman
Jan 2, 2004·The American Journal of Psychiatry·Mark S Bauer, Landis Mitchner
May 15, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Robert M A Hirschfeld
Sep 4, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Deborah A PerlickBruce G Link
Nov 16, 2004·Bipolar Disorders·Philip B Mitchell, Gin S Malhi
Mar 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joseph M Pierre
Mar 15, 2005·Bipolar Disorders·Alan D OgilvieGuy M Goodwin
May 10, 2005·Human Psychopharmacology·Eduard Vieta
Jun 14, 2005·Bipolar Disorders·Paul E Keck
Jun 15, 2005·Bipolar Disorders·Lakshmi N YathamUNKNOWN Canadian Network for Mood and Anxiety Treatments
Jul 5, 2005·The American Journal of Psychiatry·Joseph R CalabreseJamie Mullen
Oct 28, 2005·Harvard Review of Psychiatry·Michael E Thase
Nov 11, 2005·Expert Review of Neurotherapeutics·Siegfried F Kasper
Nov 18, 2005·Health and Quality of Life Outcomes·Erin E MichalakRaymond W Lam
Feb 7, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Adriano B L TortDiogo R Lara
Mar 29, 2006·The Journal of Clinical Psychiatry·Colin A DeppDilip V Jeste
Aug 12, 2006·Current Treatment Options in Neurology·Philip M Becker
Nov 18, 2006·Journal of Clinical Psychopharmacology·Michael E ThaseUNKNOWN BOLDER II Study Group
Dec 13, 2006·Bipolar Disorders·Roger S McIntyreSidney H Kennedy
Mar 30, 2007·The New England Journal of Medicine·Gary S SachsMichael E Thase

❮ Previous
Next ❯

Citations

Sep 14, 2010·Advances in Therapy·Mario A Cristancho, Michael E Thase
Jul 30, 2014·Forensic Science International : Synergy·Tina M BinzCleo L Crunelle
Aug 19, 2014·The Journal of Pharmacy and Pharmacology·Anna PartykaAnna Wesołowska
May 26, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Janusz K RybakowskiUNKNOWN EUFEST Study Group
Aug 5, 2015·Journal of Child and Adolescent Psychiatric Nursing : Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc·Doris M Van Byssum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.